ParagJitendraParikhMD

Radiation Oncology • Detroit, MI

Director, MR-guided Radiation Therapy & Director of GI Radiation Oncology, Henry Ford Cancer Institute

Join to view full profile

Dr. Parikh is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
Connect with colleagues in the same hospital or clinic.
Read the latest clinical news, personalized to your specialty.

See Dr. Parikh's full profile

Already have an account?

Office
2800 W. Grand Blvd.
Detroit, MI 48202
Phone+1 313-652-2400

Education & Training

Washington University/B-JH/SLCH ConsortiumResidency, Radiation Oncology, 2002 - 2006
Washington University/B-JH/SLCH ConsortiumInternship, Internal Medicine, 2001 - 2002
Washington University in St. Louis School of MedicineClass of 2001

Certifications & Licensure

MI State Medical License 2018 - 2025
IL State Medical License 2012 - 2020
MO State Medical License 2006 - 2019
American Board of Radiology Radiation Oncology

Awards, Honors, & Recognition

CMS Meaningful Use Stage 1 Certification MOSAIQ EMR, Elekta, 2012-2013

Clinical Trials

Registry Study of Neoadjuvant Chemoradiation & Transplant for Cholangiocarcinoma Patients Start of enrollment: 2005 Aug 12
Terminated
Five Fractions of Radiotherapy Followed by Full Dose FOLFOX Chemotherapy as Preoperative Treatment for Rectal Cancer Start of enrollment: 2009 Nov 01
Completed
Phase 2
Stereotactic Body Radiotherapy for Hepatocellular Carcinoma, and Intrahepatic Cholangiocarcinoma Start of enrollment: 2009 Dec 16
Completed
Phase 1
Microsphere Localization Using PET/MRI or PET/CT in Patients Following Radioembolization Start of enrollment: 2012 Oct 25
Terminated
Phase 1
Probiotic LGG for Prevention of Side Effects in Patients Undergoing Chemoradiation for Gastrointestinal Cancer Start of enrollment: 2014 Aug 19
Terminated
Phase 1
Gene Expression and FDG PET/MRI in Evaluating Treatment Response in Patients With Locally Advanced Rectal Cancer Undergoing Chemotherapy and Radiation Therapy Before Surgery Start of enrollment: 2014 Jun 01
Terminated
Phase 1
Local Ablative Strategies After Endovascular Radioembolization Start of enrollment: 2016 Jan 19
Terminated
Phase 1
Non-Operative Radiation Management of Adenocarcinoma of the Lower Rectum Start of enrollment: 2016 May 27
Completed
Phase 2
Daily Online Adaptation Versus Localization for MRI-Guided SBRT for Unresectable Primary or Oligometastatic Abdominal Malignancies Start of enrollment: 2017 Jan 19
Terminated
Phase 2
Stereotactic MRI-guided On-table Adaptive Radiation Therapy (SMART) for Locally Advanced Pancreatic Cancer Start of enrollment: 2019 Jan 01
Active, not recruiting
Not Applicable
Phase 2b Study of GC4711 in Combination With SBRT for Nonmetastatic Pancreatic Cancer Start of enrollment: 2021 May 07
Terminated
Phase 2
Join now to see all

Publications & Presentations

PubMed

MR-guided stereotactic radiotherapy of infra-diaphragmatic oligometastases: Evaluation of toxicity and dosimetric parameters.
Mette van Overeem Felter, Pia Krause Møller, Mirjana Josipovic, Susanne Nørring Bekke, Uffe Bernchou
Radiotherapy and Oncology. 2024-03-01
20 citations
Stereotactic MR-guided on-table adaptive radiation therapy (SMART) for borderline resectable and locally advanced pancreatic cancer: A multi-center, open-label phase 2...
Michael D Chuong, Percy Lee, Daniel A Low, Joshua Kim, Kathryn E Mittauer
Radiotherapy and Oncology. 2024-02-01
4 citations
The Use of MR-Guided Radiation Therapy for Pancreatic Cancer.
Lois A Daamen, Parag J Parikh, William A Hall
Seminars in Radiation Oncology. 2024-01-01

Press Mentions

Study Shows Promising Safety, Patient Outcomes Data for MRI-Guided Adaptive Radiation Therapy to Treat Pancreatic CancerNovember 21st, 2022
Looking Ahead to ASTRO: Keynotes, Awards and Scientific Session UpdatesOctober 6th, 2022
Henry Ford Health 1st in World to Offer Newest MR-Guided Radiation TherapyJune 3rd, 2022
Join now to see all